The cholinergic drug pilocarpine may cause sweating and salivation, nausea, vomiting and diarrhoea, and bronchospasm.
The care of a woman with autoimmune thyroid disease who becomes pregnant presents two problems: the effect which the maternal disease may have on the fetus and newborn, and the influence which pregnancy itself may have on the maternal disease.
A successful normal pregnancy assumes the adjustment of the mother's immune system to an antigenically foreign fetoplacental unit. For reasons still uncertain the maternal immune response is generally suppressed progressively through pregnancy.' This is manifested by a decreased blastogenic response of mitogen stimulated lymphocytes, a fall in the serum concentration of the IgG immunoglobulins, and alterations in the numbers of peripheral blood T lymphocyte series variably reported as More recently blocking antibodies interacting with the thyrotrophin receptor have been recognised in autoimmune thyroid disease. These antibodies block the action of thyrotrophin on the thyroid and so can be responsible for hypothyroidism in some patients with myxoedema and Hashimoto's disease. During pregnancy such antibodies cross the placenta and are one cause, albeit rare, of intrauterine and neonatal hypothyroidism; this remits spontaneously as the maternal immunoglobulins disappear from the child's circulation.7 Combinations of stimulating and blocking antibodies may interact with the fetal and neonatal thyroid, and-depending on their affinities and relative titres-lead to varying alterations of thyroid function-for example, hypothyroidism progressing to hyperthyroidism, which then remits.89
The clinical message is that serum concentrations of thyrotrophin receptor antibodies should be checked in the third trimester of pregnancy in all women with autoimmune thyroid disease-namely, Graves' disease, Hashimoto's disease, and myxoedema. Several assays are available, but the most convenient and widely available is that depending on the inhibition of labelled thyrotrophin binding to solubilised thy .otrophin receptors by the receptor antibodies.'0 Children born to mothers with high titres of thyrotrophin receptor antibody are at risk of developing one of the neonatal thyroid syndromes.
Pregnancy also has profound effects on the autoimmune thyroid diseases. Studies from both Japan and NorLh America have shown changes in clinical thyroid state and in biochemical and serological measurements during pregnancy and after birth. In a study of 41 pregnancies in 35 patients with Graves' disease in remission Amino et a! showed recurrence of disease in early pregnancy and after delivery and amelioration in the latter half of pregnancy.1" They had previously shown a fall in circulating concentrations of thyroglobulin and microsomal antibodies during pregnancy followed by rises post partum in patients with Graves 
